CASP1 and neoplasm: In the context of PANC, it has been demonstrated that the inhibition or deletion of components of the NLRP3 inflammasome, such as caspase-1, decreases tumor growth and metastasis in PANC by reprogramming innate and adaptive immunity in the tumor microenvironment [13].